Bipolar Disorder

>

Latest News

FDA
New NDA Submitted: Bysanti to Treat Acute Bipolar I and Schizophrenia

April 1st 2025

Vanda Pharmaceuticals has submitted an NDA for approval of Bysanti for the treatment of acute bipolar I disorder and schizophrenia.

bipolar
How to Decide Whether Depressions Are Bipolar Depressions

March 14th 2025

bipolar
BHV-7000 for Bipolar Disorder Fails in Phase 2/3 Trial

March 4th 2025

Andril Ylanskyl/AdobeStock
Agree to Disagree: A Collaborative Perspective From a Treatment Team and Disagreeing Patient

February 26th 2025

bipolar
FDA Accepts sNDA for Uzedy Extended-Release Injectable Suspension for Bipolar I Disorder

February 25th 2025

Latest CME Events & Activities

Expert Perspectives in the Recognition and Management of Postpartum Depression

View More

Southern California Psychiatry Conference

July 11-12, 2025

Register Now!

SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era

View More

BURST CME™ Part I: Understanding the Impact of Huntington’s Disease

View More

Expert Illustrations & Commentaries™: New Targets for Treatment in Cognitive Impairment in Schizophrenia – The Role of NMDA Receptors and Co-agonists

View More

Burst CME™ Part II: The Evolving Treatment Landscape for Huntington Disease

View More

Clinical ShowCase: Developing a Personalized Treatment Plan for a Patient with Huntington’s Disease Associated Chorea

View More

Community Practice Connections™: Optimizing the Management of Tardive Dyskinesia—Addressing the Complexity of Care With Targeted Treatment

View More

PER Psych Summit: Integrating Shared Decision-Making Into Management Plans for Patients With Schizophrenia

View More

Southern Florida Psychiatry Conference

November 21-22, 2025

Register Now!

Managing Negative Symptoms of Schizophrenia: Can Prescription Digital Therapeutics Make an Impact?

View More

Optimizing Care for Patients With Tardive Dyskinesia

View More

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

View More

More News

© 2025 MJH Life Sciences

All rights reserved.